Lomotil

OTHER3 trials

Sponsors

Mayo Clinic, National Cancer Institute (NCI)

Conditions

Granulosa Cell Ovarian CancerLymphomaLymphomasMetastatic Colon CarcinomaNSCLCSarcoma, Alveolar Soft PartSolid Tumors

Phase 1

TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas

CompletedNCT01851369

National Cancer Institute (NCI)Granulosa Cell Ovarian Cancer, Lymphomas, Metastatic Colon Carcinoma +2

Start: 2013-07-12End: 2023-08-01Updated: 2024-05-08

Phase 2

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

CompletedNCT01391962

National Cancer Institute (NCI)Sarcoma, Alveolar Soft Part

Start: 2011-07-18End: 2026-01-16Updated: 2026-02-02

Phase 3

Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET

CompletedNCT00583323

Mayo ClinicLymphoma

Start: 2003-02-28End: 2005-09-30Updated: 2014-08-21

Related Papers

Phase 2 trial of TRC102 (methoxyamine HCl) with temozolomide (TMZ) in patients with granulosa cell ovarian cancer.

Journal of Clinical Oncology2023-06-011 citations

Abstract CT168: Randomized phase 2 trial of sunitinib or cediranib in alveolar soft part sarcoma

Cancer Research2022-06-15

Abstract LB-293: A Phase II trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed metastatic colorectal carcinoma

Cancer Research2019-07-011 citations

Abstract LB-293: A Phase II trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed metastatic colorectal carcinoma

Molecular and Cellular Biology / Genetics2019-07-01

Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.

2019-05-3166 citations

A phase I trial of TRC102 (methoxyamine HCl) with temozolomide (TMZ) in patients with solid tumors and lymphomas.

Journal of Clinical Oncology2017-05-201 citations

A phase 1 trial of TRC102 (methoxyamine HCl) with temozolomide (TMZ) in patients with solid tumors and lymphomas.

Journal of Clinical Oncology2016-05-204 citations